Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sorin Group makes €4.2mm equity investment in HighLife; gets option to buy company

Executive Summary

Cardiovascular device maker Sorin Group SPA has made a €4.2mm ($5.4mm) minority equity investment in HighLife SAS, a closely held device company that is working on a transcatheter mitral valve replacement system (TMVRS) for patients with mitral regurgitation.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity

Related Companies